266 related articles for article (PubMed ID: 12632553)
21. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
22. Case of the month. Hepatic and renal failure in a patient taking troglitazone and metformin.
Chaudhry MU; Simmons DL
J Ark Med Soc; 2001 Jul; 98(1):16-9. PubMed ID: 11452755
[TBL] [Abstract][Full Text] [Related]
23. A novel antidiabetic drug, troglitazone--reason for hope and concern.
Imura H
N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
[No Abstract] [Full Text] [Related]
24. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
[No Abstract] [Full Text] [Related]
25. Serious liver injury. Leading reason for drug removals, restrictions.
Meadows M
FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
[No Abstract] [Full Text] [Related]
26. [Clinical results of troglitazone (CS-045)].
Iwamoto Y
Nihon Rinsho; 1997 Nov; 55 Suppl():131-6. PubMed ID: 9434456
[No Abstract] [Full Text] [Related]
27. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
28. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
Iuorno MJ; Nestler JE
Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
[No Abstract] [Full Text] [Related]
29. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications".
South D
J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716
[No Abstract] [Full Text] [Related]
30. Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination.
Fukano M; Amano S; Sato J; Yamamoto K; Adachi H; Okabe H; Fujiyama Y; Bamba T
Hum Pathol; 2000 Feb; 31(2):250-3. PubMed ID: 10685643
[TBL] [Abstract][Full Text] [Related]
31. [Meta-analysis shows: insulin sensitizer is safe for the liver].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
[No Abstract] [Full Text] [Related]
32. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
Algenstaedt P; Hamann A
Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
[No Abstract] [Full Text] [Related]
33. Antidiabetic treatment for NASH?
Maher J
Hepatology; 2001 May; 33(5):1338-9. PubMed ID: 11343267
[No Abstract] [Full Text] [Related]
34. Insulin sensitizers for polycystic ovary syndrome.
Baillargeon JP; Iuorno MJ; Nestler JE
Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
[No Abstract] [Full Text] [Related]
35. Acute rhabdomyolysis associated with troglitazone.
Yokoyama M; Izumiya Y; Yoshizawa M; Usuda R
Diabetes Care; 2000 Mar; 23(3):421-2. PubMed ID: 10868879
[No Abstract] [Full Text] [Related]
36. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
Baskin S; Neher JO; Dodson S; Hoffman R
J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064
[No Abstract] [Full Text] [Related]
37. Combination agents for diabetes.
Samuel J; Rochester CD
Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
[No Abstract] [Full Text] [Related]
38. Diabetes drug withdrawn after reports of hepatic events.
Wise J
BMJ; 1997 Dec; 315(7122):1564. PubMed ID: 9437272
[No Abstract] [Full Text] [Related]
39. Drugs for diabetes.
Abramowicz M; Zuccotti G;
Treat Guidel Med Lett; 2005 Aug; 3(36):57-62. PubMed ID: 16012392
[No Abstract] [Full Text] [Related]
40. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
